Cugene Inc

Cugene Inc. is a clinical-stage biotechnology company headquartered in Waltham, Massachusetts. The company employs 18 people and generates an estimated $5 million in annual revenue. Cugene specializes in the development of next-generation immunology and oncology medicines. Their research focuses on leveraging specific immune cells to treat both autoimmune diseases and cancers. Cugene's approach to medicine development involves harnessing the power of the body's own immune system to target and eliminate disease-causing cells. This precision immunotherapy approach aims to provide more effective and targeted treatments for patients. For more information about Cugene Inc. and their groundbreaking research, visit their website at cugene.com.